SHINE SA, September 2020 The contraceptive implant (Implanon NXT) is one of the most effective contraceptives available. Along with the hormonal and copper IUDs, it is classified as Long Acting Reversible Contraception (LARC) which are recommended as first-line options for all people choosing to use contraception. SHINE SA wish to alert clinicians to important updated information about Implanon...
RACGP, 25th August 2020 The newly released suite consists of five intrauterine device (IUD) resources, including a checklist and patient confirmation form, patient pre- and post-insertion checklist, practitioner checklist and disclaimer. Current evidence-based options for pain relief during IUD procedures are provided as an appendix. Dr Amy Moten, Chair of the RACGP Specific Interests Sexual...
July 2020 There are changes to Telehealth from Monday, July 20th which mean that clients who have not attended a service within the last 12 months – that is, new clients or clients who have not used a service in the last 12 months – will no longer be eligible for a Telehealth appointment. Marie Stopes Australia has written an open letter about the impact of this change access to...
Burnet Institute, 28 May, 2020 Burnet Institute is a member of a consortium of Australian-based non-governmental organisations (NGOs) and academic institutes concerned about the detrimental effects of the COVID-19 pandemic on the sexual and reproductive health and rights of women and girls globally. The International Sexual and Reproductive Health and Rights Consortium, which includes Save the...
SHINE SA, May 2020 Filled with quality clinical guidance and tips for best practice, SHINE SA’s new Sexual Health Matters – Clinical Podcast delves into the intimate regions of the body and broaches the uncomfortable conversations necessary to ensure client safety and sexual/reproductive well-being. Through discussion, interview and explanation, experienced sexual health clinicians raise...
Evofem Biosciences via PRNewswire, May 22nd 2020 Evofem Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Phexxi is the first non-hormonal, on-demand...